Get started
Award

1K12HS026395

Funded outputs count: 8
Funder award ID: 1K12HS026395
OpenAlex ID: G6319106986
Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis
2022 · Cosby A. Stone, Lacey B. Robinson, et al. · The Journal of Allergy and Clinical Immunology In Practice · 6
PDF
Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy
2022 · Maria A. Bruusgaard-Mouritsen, Grace Koo, et al. · The Journal of Allergy and Clinical Immunology In Practice · 12
PDF
mRNA COVID-19 vaccine safety in patients with previous immediate hypersensitivity to pegaspargase
2021 · Grace Koo, Sara Anvari, et al. · The Journal of Allergy and Clinical Immunology In Practice · 19
PDF
Prevalence, Costs, and Consequences of Low-Value Preprocedural Urinalyses in the US
2021 · Erica S. Shenoy, Mia Amalia Giuriato, et al. · JAMA Internal Medicine · 13
PDF
An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history
2021 · Matthew S. Krantz, Cosby A. Stone, et al. · The Journal of Allergy and Clinical Immunology In Practice · 7
PDF
Anaphylaxis to the first dose of mRNA SARS‐CoV‐2 vaccines: Don't give up on the second dose!
2021 · Matthew S. Krantz, Maria A. Bruusgaard‐Mouritsen, et al. · Allergy · 65
PDF
Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System
2021 · Sara Beth Bluestein, Roger Yu, et al. · The Journal of Allergy and Clinical Immunology In Practice · 37
Breaking the Mold: Safely Delabeling Penicillin Allergies in Hospitalized Children
2021 · James W. Antoon, Alison G. Grisso, et al. · Hospital Pediatrics · 4
PDF
Year
Topic